PMID: 15247616Jul 13, 2004Paper

Resistant Candida parapsilosis associated with long term fluconazole prophylaxis in an animal model

The Pediatric Infectious Disease Journal
Bradley A YoderJacqueline J Coalson

Abstract

We report an increased occurrence of fluconazole-resistant Candida parapsilosis after a 4-year period of antifungal prophylaxis in a premature animal neonatal intensive care unit. Although prevention of nosocomial fungal infections in premature infants is desirable, implementation of fluconazole prophylaxis should be undertaken with caution. Where such programs are in place, evaluation of fungal isolates for drug resistance should be considered.

References

Sep 1, 1993·Clinical Pharmacology and Therapeutics·H SaxénM Pohjavuori
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·J J CoalsonB A Yoder
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Jan 5, 2002·The New England Journal of Medicine·G SchnyderO M Hess
Jan 5, 2002·The New England Journal of Medicine·D KaufmanL G Donowitz
Jan 31, 2002·The Annals of Pharmacotherapy·William T Sypula, Pramodini B Kale-Pradhan
Jan 25, 2003·Current Opinion in Pediatrics·Rachel L Chapman

❮ Previous
Next ❯

Citations

Nov 26, 2009·The Pediatric Infectious Disease Journal·Mariam AzizJames B McAuley
Jan 24, 2013·The Pediatric Infectious Disease Journal·Mohan PammiJoseph M Bliss
May 14, 2008·Current Opinion in Pediatrics·David A Kaufman
Apr 27, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·Brian A McCrossanDavid G Sweet
May 31, 2008·Journal of Perinatology : Official Journal of the California Perinatal Association·D A Kaufman
Oct 14, 2009·Critical Reviews in Microbiology·Eveline C van AsbeckDavid A Stevens
Jul 30, 2008·Expert Review of Anti-infective Therapy·David A Kaufman
Oct 4, 2012·Expert Review of Anti-infective Therapy·Brian D W ChowJoseph M Bliss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.